aiqbench takeQuantum Computing

NVision Quantum has secured €2.5 million in Horizon Europe funding to expand its POLARIS quantum-enhanced MRI platform, specifically targeting improved detection of brain metastases through metabolic imaging research. This initiative leverages a consortium involving Yonsei University and Ulm University to develop higher-resolution workflows that address current limitations in standard MRI diagnostics for cancer patients. The project represents a significant step toward integrating quantum optimization into medical hardware infrastructure rather than focusing on general-purpose computing algorithms.

Sources coveringQuantum Zeitgeist, Quantum Computing Report

What this isA model's reading of the article and related coverage, written for aiqbench. Not the publisher's words.

NVision Quantum Expands POLARIS Platform with RESQ Project Funding

Quantum ZeitgeistJuly 28, 20264 min read

NVision Quantum secured €2.5 million Horizon Europe funding for RESQ, advancing their POLARIS quantum-enhanced MRI platform.

€2.5 million in Horizon Europe funding will accelerate the development of NVision Quantum Technologies’ POLARIS platform and establish a new metabolic imaging research center at Yonsei University in South Korea. The three-year RESQ project aims to improve image resolution and sensitivity for detecting brain metastases, a challenge impacting roughly one in five cancer patients. This expansion marks NVision’s entry into the Asian market and builds upon existing POLARIS deployments in Europe and the United…

Excerpt shown under the publisher's RSS terms · 74 words · full text and figures are on the publisher's site

Read at Quantum Zeitgeist ↗Ask about this article